ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Obesity
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1652678
Patterns of Multimorbidity Across Obesity Severity and Fat Distribution in Anhui, China: A Community-Based Study
Provisionally accepted- 1Suzhou hospital of Anhui Medical University, China, Suzhou, China
- 2Anhui Medical University, Hefei, China
- 3Anhui Medical University School of Public Health, Hefei, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Obesity and multimorbidity are prevalent worldwide. However, the relationships of obesity severity and fat distribution with multimorbidity patterns among the Chinese population are still unclear. We sought to investigate multimorbidity patterns among people with various obesity severity and fat distribution in Anhui, China. Methods: We used cross-sectional data including 123,148 adults aged 35-76 years in 12 districts from Anhui Province, China. We used logistic regression models, stratified by gender, to analyze the associations of different obesity severity and fat distribution with the risk of multimorbidity by adjusting for confounders of age, region, marriage, education level, annual income, insurance, smoking, drinking, rational diet, weight control, physical exercise, adequate sleep and regular checkup. Subgroup and interaction analyses examined how varying obesity severity and fat distribution relate to multimorbidity risk. Association rule mining (ARM) utilized the Apriori algorithm to analyze disease combinations under different obesity subgroups in males and females. Results: Multimorbidity occurred in 10.3%(n=12,644) of the participants, with 10.7%(n=5,324) in males and 9.96% (n=7,320) in females, and the majority (80.5%, n=10,177) had two chronic diseases. Compared to normal-weight participants, there were progressively higher odds of multimorbidity in overweight, mild, moderate, and severe obesity in both males and females (P for trend <0.001). Individuals with general obesity (male: OR = 1.366, 95% CI: 1.234–1.513; female: OR = 1.315, 95% CI: 1.197–1.445), central obesity (male: OR = 2.168, 95% CI: 1.857–2.532; female: OR = 1.567, 95% CI: 1.401–1.752), or compound obesity (male: OR = 2.223, 95% CI: 1.996–2.476; female: OR = 1.998, 95% CI: 1.822–2.190) had significantly higher multimorbidity rates than their non-obese counterparts. Subgroup analysis and interaction analysis results showed that males, people aged < 60 years, and smokers may worsen the effects of obesity on multimorbidity. ARM revealed that the disease cluster comprising diabetes, hypertension, and dyslipidemia exhibited the strongest association. Conclusions: Both overweight and obesity are independent risk factors for multimorbidity, and males exhibit significantly higher multimorbidity risks than females. Individuals with obesity are more vulnerable to multiple coexisting conditions such as diabetes, hypertension, and dyslipidemia. Therefore, adopting health management and intervention measures for obesity individuals can help control multimorbidity.
Keywords: multimorbidity, Body Mass Index, Fat distribution, Central obesity, association rule mining
Received: 24 Jun 2025; Accepted: 25 Aug 2025.
Copyright: © 2025 Gu, Wang, Yi, Gu, Fu and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Weiqiang Wang, Suzhou hospital of Anhui Medical University, China, Suzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.